Connection

Angelina Passaro to Animals

Back to Details
This is a "connection" page, showing publications Angelina Passaro has written about Animals.
Angelina Passaro
Connection Strength
0.058
Animals
  1. Brigatinib for the treatment of ALK-positive advanced non-small cell lung cancer patients. Drugs Today (Barc). 2017 Aug; 53(8):435-446.
    View in: PubMed
    Score: 0.021
  2. Targeting EGFR T790M mutation in NSCLC: From biology to evaluation and treatment. Pharmacol Res. 2017 03; 117:406-415.
    View in: PubMed
    Score: 0.021
  3. Concise Review: Resistance to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer: The Role of Cancer Stem Cells. Stem Cells. 2018 05; 36(5):633-640.
    View in: PubMed
    Score: 0.006
  4. Combination immunotherapy strategies in advanced non-small cell lung cancer (NSCLC): Does biological rationale meet clinical needs? Crit Rev Oncol Hematol. 2017 Nov; 119:30-39.
    View in: PubMed
    Score: 0.005
  5. Co-activation of STAT3 and YES-Associated Protein 1 (YAP1) Pathway in EGFR-Mutant NSCLC. J Natl Cancer Inst. 2017 09 01; 109(9).
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.